Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

Caissa Troutman, MD By comparison, non-pharmacological caloric ... Anila Chadha, MD, recommends that patients on GLP-1 agonists aim for 30 g of protein at every meal and emphasize both protein ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.